Thomas Stevens, CFA" »

Taysha Gene Therapies shares owned by Thomas Stevens, CFA"

Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by Thomas Stevens, CFA" from 13F filings

Historical chart of Thomas Stevens, CFA" investment in Taysha Gene Therapies

Tip: Access up to 7 years of quarterly data

All positions including Taysha Gene Therapies held by Thomas Stevens, CFA" consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taysha Gene Therapies by Thomas Stevens, CFA"

Quarter filed Position value Share count Share price at filing
2025-12-31 $162k 33k 4.91
2025-06-30 $272k 118k 2.31
2025-03-31 $199k 143k 1.39
2024-12-31 $238k 138k 1.73
2024-09-30 $416k 207k 2.01

More positions owned by Thomas Stevens, CFA"

NVIDIA Corp Common Stock (NVDA)
Apple Common Stock (AAPL)
Microsoft Corp Common Stock (MSFT)
Broadcom Common Stock (AVGO)
Meta Platforms Common Stock (META)
Amazon.com Common Stock (AMZN)
Alphabet Common Stock (GOOG)
Alphabet Common Stock (GOOGL)
Netflix Common Stock (NFLX)
AbbVie Common Stock (ABBV)
Gilead Sciences Common Stock (GILD)
Tesla Common Stock (TSLA)
General Electric Common Stock (GE)
Merck & Co Common Stock (MRK)
Amphenol Corp Common Stock (APH)

View all positions for Thomas Stevens, CFA"

Top funds holding Taysha Gene Therapies

RA Capital Management
venBio Select Advisor
BlackRock
Rtw Investments
FMR
Vestal Point Capital
Goldman Sachs Group
Vanguard Group
State Street Corporation
Siren
Octagon Capital Advisors
Polar Capital Holdings
Barclays
Geode Capital Management
Millennium Management

View all funds holding Taysha Gene Therapies